Literature DB >> 23740086

Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study.

S O'Donnell1.   

Abstract

UNLABELLED: Using administrative data healthcare databases from five Canadian provinces, we compared prevalence estimates of diagnosed osteoporosis and incidence rates for related fractures in Canada. The algorithms adopted showed consistent age and sex patterns across all provinces and will be suitable for national surveillance and monitoring.
PURPOSE: This study aims to evaluate the feasibility of using provincial population-based administrative data to develop a national surveillance system of diagnosed osteoporosis and related fractures (forearm, humerus, vertebra, pelvis, and hip) in Canada.
METHODS: Linked healthcare databases from five provinces representing approximately 85 % of the Canadian population were used. Multiple algorithms combining hospitalizations, physician visits, and osteoporosis prescription drug dispensations were evaluated in each province. The adopted algorithms for diagnosed osteoporosis and incident fractures combined hospitalizations and physician visits based on 3 years and 1 year of data, respectively. Sex-specific age-standardized osteoporosis prevalence and fracture incidence rates were estimated for each province from 1995/1996 to 2007/2008.
RESULTS: Age-standardized prevalence of diagnosed osteoporosis in those ≥50 years increased over the study period but stabilized in the most recent years. Using the adopted algorithm produced provincial estimates ranging from 5.6 to 10.5 % for 2007/2008, with consistent age and sex patterns across provinces. The use of osteoporosis drug data resulted in higher osteoporosis estimates compared with estimates without drug data. Age-standardized incidence of fractures in those ≥40 years showed similar age and sex patterns across all provinces. The highest level of agreement among provinces was for hip and humerus fracture rates, with wider provincial variation for forearm, vertebra, and pelvis fractures.
CONCLUSIONS: Our results are consistent with previous validation works and confirm that the algorithms adopted will be suitable for the national monitoring of diagnosed osteoporosis and related fractures. A similar approach may be applicable to other countries with high-quality administrative data.

Entities:  

Mesh:

Year:  2013        PMID: 23740086      PMCID: PMC5096934          DOI: 10.1007/s11657-013-0143-2

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  19 in total

1.  Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data.

Authors:  Pongthorn Narongroeknawin; Nivedita M Patkar; Bita Shakoory; Archana Jain; Jeffrey R Curtis; Elizabeth Delzell; Philip H Lander; Robert R Lopez-Ben; Michael J Pitt; Monika M Safford; David A Volgas; Kenneth G Saag
Journal:  J Clin Densitom       Date:  2011-11-09       Impact factor: 2.617

2.  Bone health: osteoporosis, calcium and vitamin D.

Authors:  Didier Garriguet
Journal:  Health Rep       Date:  2011-09       Impact factor: 4.796

3.  An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.

Authors:  O Johnell; J A Kanis
Journal:  Osteoporos Int       Date:  2006-09-16       Impact factor: 4.507

4.  Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.

Authors:  W D Leslie; L M Lix; L Langsetmo; C Berger; D Goltzman; D A Hanley; J D Adachi; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2010-12-16       Impact factor: 4.507

5.  "Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures?

Authors:  J R Curtis; A J Taylor; R S Matthews; M N Ray; D J Becker; L C Gary; M L Kilgore; M A Morrisey; K G Saag; A Warriner; E Delzell
Journal:  Osteoporos Int       Date:  2009-01-29       Impact factor: 4.507

6.  Identification and validation of vertebral compression fractures using administrative claims data.

Authors:  Jeffrey R Curtis; Amy S Mudano; Daniel H Solomon; Juan Xi; Mary Elkins Melton; Kenneth G Saag
Journal:  Med Care       Date:  2009-01       Impact factor: 2.983

7.  Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006.

Authors:  B Abrahamsen; P Vestergaard
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

8.  Trend of hip fracture incidence in Germany 1995-2004: a population-based study.

Authors:  A Icks; B Haastert; M Wildner; C Becker; G Meyer
Journal:  Osteoporos Int       Date:  2007-12-18       Impact factor: 4.507

9.  Updated fracture incidence rates for the US version of FRAX.

Authors:  B Ettinger; D M Black; B Dawson-Hughes; A R Pressman; L J Melton
Journal:  Osteoporos Int       Date:  2009-08-25       Impact factor: 4.507

10.  Utilization of routinely collected administrative data in monitoring the incidence of aging dependent hip fracture.

Authors:  Reijo Sund
Journal:  Epidemiol Perspect Innov       Date:  2007-06-07
View more
  27 in total

1.  Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.

Authors:  Micaela Jantzi; Amy C Maher; George Ioannidis; John P Hirdes; Lora M Giangregorio; Alexandra Papaioannou
Journal:  Age Ageing       Date:  2014-11-14       Impact factor: 10.668

2.  Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry.

Authors:  William D Leslie; Helena Johansson; Eugene V McCloskey; Nicholas C Harvey; John A Kanis; Didier Hans
Journal:  J Bone Miner Res       Date:  2018-07-16       Impact factor: 6.741

3.  Five-year refracture rates of a province-wide fracture liaison service.

Authors:  R Sujic; D E Beaton; M Mamdani; S M Cadarette; J Luo; S Jaglal; J E M Sale; R Jain; E Bogoch
Journal:  Osteoporos Int       Date:  2019-05-31       Impact factor: 4.507

4.  Fracture Risk in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study.

Authors:  William D Leslie; Suzanne N Morin; Lisa M Lix; Saroj Niraula; Eugene V McCloskey; Helena Johansson; Nicholas C Harvey; John A Kanis
Journal:  Oncologist       Date:  2019-07-10

5.  Effects of obesity and diabetes on rate of bone density loss.

Authors:  W D Leslie; S N Morin; S R Majumdar; L M Lix
Journal:  Osteoporos Int       Date:  2017-09-15       Impact factor: 4.507

6.  FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.

Authors:  W D Leslie; S R Majumdar; S N Morin; L M Lix; H Johansson; A Oden; E V McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2017-06-07       Impact factor: 4.507

7.  Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.

Authors:  S Yang; W D Leslie; Y Luo; A L Goertzen; S Ahmed; L M Ward; I Delubac; L M Lix
Journal:  Osteoporos Int       Date:  2017-10-06       Impact factor: 4.507

Review 8.  Temporal trends in the incidence of osteoporotic fractures.

Authors:  S N Morin; L M Lix; S R Majumdar; W D Leslie
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

9.  A population-based study of postfracture care in Manitoba, Canada 2000/2001-2014/2015.

Authors:  Y Cui; L M Lix; S Yang; S N Morin; W D Leslie
Journal:  Osteoporos Int       Date:  2019-07-02       Impact factor: 4.507

10.  Comparative trends in incident fracture rates for all long-term care and community-dwelling seniors in Ontario, Canada, 2002-2012.

Authors:  A Papaioannou; C C Kennedy; G Ioannidis; C Cameron; R Croxford; J D Adachi; S Mursleen; S Jaglal
Journal:  Osteoporos Int       Date:  2016-01-22       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.